ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Gyre Therapeutics Inc

Gyre Therapeutics Inc (GYRE)

10.80
-0.13
(-1.19%)
At close: January 16 4:00PM
10.80
0.00
( 0.00% )
After Hours: 4:30PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
10.80
Bid
10.60
Ask
10.86
Volume
78,155
10.60 Day's Range 11.11
8.26 52 Week Range 26.37
Market Cap
Previous Close
10.93
Open
11.03
Last Trade
1
@
10.3
Last Trade Time
16:30:17
Financial Volume
$ 844,423
VWAP
10.8045
Average Volume (3m)
106,606
Shares Outstanding
93,521,434
Dividend Yield
-
PE Ratio
-10.86
Earnings Per Share (EPS)
-0.99
Revenue
113.45M
Net Profit
-92.93M

About Gyre Therapeutics Inc

Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. It mainly focuses on developing novel medicines to address serious medical conditions for individuals in need of treatment options. The company emphasizes product development efforts in the field of hemostasis and to develop val... Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. It mainly focuses on developing novel medicines to address serious medical conditions for individuals in need of treatment options. The company emphasizes product development efforts in the field of hemostasis and to develop valuable therapies for individuals with hemophilia. It is engaged in the clinical development of improved, next-generation subcutaneous prophylaxis using enhanced potency Factor VIIa and Factor IX variants. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Gyre Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GYRE. The last closing price for Gyre Therapeutics was $10.93. Over the last year, Gyre Therapeutics shares have traded in a share price range of $ 8.26 to $ 26.37.

Gyre Therapeutics currently has 93,521,434 shares outstanding. The market capitalization of Gyre Therapeutics is $1.02 billion. Gyre Therapeutics has a price to earnings ratio (PE ratio) of -10.86.

GYRE Latest News

Gyre Therapeutics Announces the Appointment of Ping Zhang to Board of Directors

SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with clinical development programs focusing on...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.86828.741617833639.931811.07999.5111363410.29273857CS
4-0.39-3.4852546916911.1914.42289.5112921210.98018441CS
12-3.16-22.636103151913.96199.5110660611.64086223CS
26-3.24-23.076923076914.04198.267539412.16990847CS
52-11.88-52.38095238122.6826.378.267652113.65482252CS
1563.854.2857142857730.45.888336115.26814868CS
2603.854.2857142857730.45.888336115.26814868CS

GYRE - Frequently Asked Questions (FAQ)

What is the current Gyre Therapeutics share price?
The current share price of Gyre Therapeutics is $ 10.80
How many Gyre Therapeutics shares are in issue?
Gyre Therapeutics has 93,521,434 shares in issue
What is the market cap of Gyre Therapeutics?
The market capitalisation of Gyre Therapeutics is USD 1.02B
What is the 1 year trading range for Gyre Therapeutics share price?
Gyre Therapeutics has traded in the range of $ 8.26 to $ 26.37 during the past year
What is the PE ratio of Gyre Therapeutics?
The price to earnings ratio of Gyre Therapeutics is -10.86
What is the cash to sales ratio of Gyre Therapeutics?
The cash to sales ratio of Gyre Therapeutics is 8.89
What is the reporting currency for Gyre Therapeutics?
Gyre Therapeutics reports financial results in USD
What is the latest annual turnover for Gyre Therapeutics?
The latest annual turnover of Gyre Therapeutics is USD 113.45M
What is the latest annual profit for Gyre Therapeutics?
The latest annual profit of Gyre Therapeutics is USD -92.93M
What is the registered address of Gyre Therapeutics?
The registered address for Gyre Therapeutics is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the Gyre Therapeutics website address?
The website address for Gyre Therapeutics is www.gyretx.com
Which industry sector does Gyre Therapeutics operate in?
Gyre Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
JSPRWJasper Therapeutics Inc
$ 0.30
(100.00%)
100
MKDWMKDWELL Tech Inc
$ 0.80
(40.35%)
29.95k
VSVersus Systems Inc
$ 2.65
(38.02%)
2.69M
NUKKNukkleus Inc
$ 28.31
(37.90%)
1.3M
VINCVincerx Inc
$ 0.167
(19.20%)
496.08k
QTIQT Imaging Holdings Inc
$ 0.4621
(-12.18%)
62.91k
RIMEAlgorhythm Holdings Inc
$ 0.0374
(-11.58%)
27.28M
RFILRF Industries Ltd
$ 4.0613
(-10.94%)
11.61k
AIMAUAimfinity Investment Corporation I
$ 11.00
(-8.33%)
1.2k
TOIOncology Institute Inc
$ 0.4451
(-8.23%)
5.18k
RIMEAlgorhythm Holdings Inc
$ 0.0374
(-11.58%)
27.28M
ENVBEnveric Biosciences Inc
$ 0.374
(6.83%)
7.52M
ACONAclarion Inc
$ 0.045
(0.00%)
5.02M
TGLTreasure Global Inc
$ 0.249
(16.19%)
3.16M
PLUGPlug Power Inc
$ 2.85
(4.01%)
3.12M

Your Recent History

Delayed Upgrade Clock